Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

119.24 -16.14 (-11.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,147,719
Open 130.00
Bid (Size) 119.25 (100)
Ask (Size) 124.00 (100)
Prev. Close 135.38
Today's Range 114.06 - 133.00
52wk Range 55.17 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019
As of mid-January 2026, the U.S. equity markets are witnessing a historic recalibration that few analysts predicted eighteen months ago. The Russell 2000 index, the benchmark for American small-cap... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
From GeneDx
Via Business Wire

Performance

YTD
-9.9%
-9.9%
1 Month
-20.8%
-20.8%
3 Month
-1.3%
-1.3%
6 Month
+44.7%
+44.7%
1 Year
+40.3%
+40.3%

More News

Read More
News headline image
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
From GeneDx
Via Business Wire
News headline image
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
From GeneDx
Via Business Wire
News headline image
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
From GeneDx
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
From GeneDx
Via Business Wire
News headline image
The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
Via Chartmill
News headline image
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
From GeneDx
Via Business Wire
News headline image
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗
Via Investor's Business Daily
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗
Via Chartmill
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
Via The Motley Fool
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
Via Benzinga
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗
Via Chartmill
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
News headline image
What Does the Market Think About GeneDx Holdings Corp? ↗
Via Benzinga
News headline image
GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 119.24
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 01/12/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.